Completed phase I studies of ME-3183 pave way for phase II studies in plaque psoriasis Aug. 24, 2021 No Comments
TYK2 inhibitor NDI-034858 enters phase II investigation for plaque psoriasis Aug. 16, 2021 No Comments
Second interim analysis data from phase IIa study of vilobelimab in pyoderma gangrenosum Aug. 11, 2021 No Comments
Phase II study of ASC-40 for the treatment of acne vulgaris approved in China Aug. 9, 2021 No Comments
Phase IIb/III ALLEGRO trial of ritlecitinib in alopecia areata meets primary efficacy endpoint Aug. 4, 2021 No Comments
Abcentra studies orticumab in subjects with psoriasis and cardiometabolic risk factors Aug. 3, 2021 No Comments
RSS